News
Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...
5h
Adweek on MSNGLP-1 Weight Loss Drugs are Disrupting Brands. The Vitamin Shoppe Is the Latest Chasing the UpsideAnd since GLP-1s come with side effects including fatigue, digestive difficulties, and loss of muscle, products to address ...
This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...
New research suggests that weight loss injections, also known as GLP-1 receptor agonists, may have a significant anti-cancer ...
Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.
Sophia Umansky, the 25-year-old daughter of Kyle Richards, is reacting to backlash over her use of a weight-loss drug, ...
The global market for Ozempic, Wegovy and similar drugs is projected to explode during the next five years. Fashion - which ...
Weight loss drugs like semaglutide could add £4.5 billion to the UK economy annually, boosting productivity and reducing ...
This story was originally published by CalMatters. Sign up for their newsletters. Popular weight loss drugs Ozempic and Wegovy would no longer be covered by Medi-Cal under a proposal unveiled by Gov.
Obesity increases the risk of numerous secondary diseases such as type 2 diabetes, high blood pressure and mental illness. Prof. Dr. Kerstin Stemmer, Professor of Molecular Cell Biology at the ...
Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are weight-loss medicines that make people feel fuller for longer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results